My research focuses on ADAM22, a newly identified protein in endocrine-resistant breast cancer. I am investigating the functional role of ADAM22 and its potential as a drug target in treating breast cancer.
Recent Posts
- Thousands turn Cork, Kilkenny & Dublin pink as Breast Cancer Ireland’s Very Pink Run 2026 raises almost €900,000 in vital funds for breast cancer research
- Lough Rea Pink Afternoon Tea in support of Breast Cancer Ireland
- Spring Raffle Results 2026
- Breast Cancer Ireland’s Annual ‘Race for a Cure’ Race Day, supported by Porsche Ireland
- AI Detects Up to 30% More Breast Cancers in Major International Trials
